AllPeptides.eu - Advanced Peptide Research
    Research-use-only hub
    2 variants

    Educational protocol hub

    IGF-1 DES: protocol variants and reconstitution resources

    Educational hub for IGF-1 DES, grouping 2 available protocol variants with links to the exact dosage and reconstitution pages.

    What this hub covers

    This page groups the available IGF-1 DES protocol variants so readers can choose the exact vial-size guide without mixing formats.

    Reconstitution workflow

    Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.

    Research-only context

    All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.

    Available protocol variants

    Choose the exact guide you want to view.

    IGF-1 DES

    1mg

    IGF-1 DES (Des(1-3) IGF-1) is a truncated form of IGF-1 that lacks the first 3 amino acids (67 vs. 70), resulting in ~10× greater potency at the IGF-1 receptor compared to native IGF-1. It has a very short half-life (~20–30 minutes), making it suitable for localized post-workout actions. It is primarily used intramuscularly in targeted muscle groups.

    View protocol

    IGF-1 DES

    2mg

    IGF-1 DES (Des(1-3) IGF-1) is a shortened form of IGF-1 (67 vs 70 amino acids), ~10x more potent at the IGF-1R. Short half-life (~20–30 minutes) - ideal for local post-workout effect. 2mg vial — reconstitute with 2 mL 0.6% acetic acid for 1 mg/mL concentration.

    View protocol

    Related research resources

    Internal links that help readers and search engines understand this peptide topic cluster.

    References

    1. Biomol Datasheet — IGF-I Des(1-3) recombinant: technical specifications, reconstitution in acetic acid
      View Source
    2. Peptides.org — IGF-1 DES dosage calculator and guide: 50–100mcg protocol
      View Source
    3. Lumin Peptides — IGF-1 DES dosing protocol: 20–40mcg IM post-workout
      View Source
    4. Ballard FJ et al. Int J Biochem Cell Biol 1996 — Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I.
      View Source
    5. Frontiers in Bioengineering — IGF-1: promising therapeutic target for peripheral nerve injury repair
      View Source

    Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu